OKE vs STRO
ONEOK Inc (OKE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the OKE and STRO stock pages for the full models.
Not investment advice.